CGM Devices for Longevity Tracking Lack Robust Evidence Despite Growing Hype
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
Insulin resistance, blood sugar regulation, metabolic syndrome, and body composition
461 articles
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
Huberman breaks down the neuroscience of sugar desire and shares practical tools to regulate blood glucose and curb cravings.
A deep mechanistic exploration of how ectopic lipid accumulation, mitochondrial dysfunction, mTOR-IRS1 feedback, and inflammatory crosstalk converge to drive age-related insulin resistance — plus emerging therapeutic strategies.
Go beyond the basics to explore the molecular machinery of insulin signaling — from receptor activation to GLUT4 translocation — and understand exactly how this cascade breaks down in insulin resistance and aging.
Explore how brown and beige fat activity declines with age, the metabolic ripple effects this creates, and the evidence-backed lifestyle strategies that can help restore thermogenic function.
Discover the three types of fat tissue in your body, what makes each one unique, and why activating the right kind could be a key to healthier aging.
Go beyond the basics and explore how GLP-1 coordinates insulin release, appetite suppression, and cellular protection — and why these mechanisms matter for long-term metabolic health.
Explore how sirtuins use NAD+ as a molecular switch to regulate aging, DNA repair, and metabolism — and what happens when this system breaks down.
A Cochrane meta-analysis of 11 RCTs finds very low-certainty evidence that liver support systems neither reduce mortality nor improve key outcomes in ALF.
A 2025 mini-review synthesizes RCTs and meta-analyses showing hypertonic dextrose prolotherapy rivals or beats standard OA injections.
A large prospective cohort study finds long-term exposure to pyrethroid pesticides raises fasting glucose, insulin resistance, and type 2 diabetes risk.
Mayo Clinic review covers every FDA-approved obesity medication plus pipeline drugs, with head-to-head weight loss data and clinical best practices.